Skip to main content
. 2024 Apr 18;12(4):439. doi: 10.3390/vaccines12040439
BD birth dose
CDC Centers for Disease Control and Prevention
CKD chronic kidney disease
CpG cytosine phosphoguanine
DC dendritic cell
DTaP diphtheria-tetanus-acellular pertussis
GSK Glaxo Smith Kline
HAV hepatitis A virus
HBV hepatitis B virus
HBIG hepatitis B immunoglobulin
HBcAg hepatitis B core antigen
HBeAg hepatitis B e antigen
HBsAg hepatitis B surface antigen
HCC hepatocellular carcinoma
HD hemodialysis
HDV hepatitis D virus
Hib Hemophilus influenza type b
HIV human immunodeficiency virus
IBD inflammatory bowel disease
IgG immunoglobulin G
IPV inactivated polio vaccine
LBW low birth weight
MSM men who have sex with men
MTCT mother-to-child transmission
PLWH people living with human immunodeficiency virus
PWID people who inject drugs
TNF tumor necrosis factor
VLP virus-like particle
WHO World Health Organization